Elo Mutual Pension Insurance’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-26,292
Closed -$561K – 596
2025
Q3
$561K Buy
26,292
+11,417
+77% +$270K 0.01% 590
2025
Q2
$321K Buy
14,875
+1,996
+15% +$37.1K 0.01% 611
2025
Q1
$214K Buy
12,879
+1,119
+10% +$20.3K ﹤0.01% 614
2024
Q4
$216K Buy
+11,760
New +$190K ﹤0.01% 523

Other funds holding ACAD

Elo Mutual Pension Insurance's ACAD Position: Q4 2025 in Review

Elo Mutual Pension Insurance sold out of Acadia Pharmaceuticals (ACAD) in Q4 2025, closing a stake of 26,292 shares — an estimated $561K sold.

Elo Mutual Pension Insurance first reported a position in ACAD in Q4 2024 and held it in 4 quarters. The position peaked at $561K in Q3 2025. 336 funds tracked by Wall St. Rank hold ACAD as of Q4 2025.

  • Elo Mutual Pension Insurance reported no remaining Acadia Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Elo Mutual Pension Insurance sold 26,292 Acadia Pharmaceuticals shares in Q4 2025, an estimated $561K.
  • Elo Mutual Pension Insurance first reported a position in Acadia Pharmaceuticals in Q4 2024 and held it in 4 quarters.
  • Elo Mutual Pension Insurance's Acadia Pharmaceuticals position peaked at $561K in Q3 2025.
  • 336 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q4 2025.

Based on Elo Mutual Pension Insurance's 13F filing for Q4 2025, filed 12 Feb 2026.